Supplementary Table (S4) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table (S4). Antigens, primary antibodies, clone, source, optimal dilution and scoring system used for each immunohistochemical marker
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361919629
